Growth hormone excess in neurofibromatosis 1
- PMID: 30283094
- DOI: 10.1038/s41436-018-0312-1
Growth hormone excess in neurofibromatosis 1
Comment in
-
Response to Hannah-Shmouni and Stratakis.Genet Med. 2019 May;21(5):1256. doi: 10.1038/s41436-018-0313-0. Epub 2018 Oct 4. Genet Med. 2019. PMID: 30283095 No abstract available.
Comment on
-
Care of adults with neurofibromatosis type 1: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).Genet Med. 2018 Jul;20(7):671-682. doi: 10.1038/gim.2018.28. Epub 2018 Apr 26. Genet Med. 2018. PMID: 30006586
References
-
- Stewart DR, Korf BR, Nathanson KL, Stevenson DA, Yohay K. Care of adults with neurofibromatosis type 1: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2018;20:671–82. - DOI
-
- Cambiaso P, Galassi S, Palmiero M, et al. Growth hormone excess in children with neurofibromatosis type-1 and optic glioma. Am J Med Genet A. 2017;173:2353–58. - DOI
-
- Hannah-Shmouni F, Beckers P, Trivellin G, Lyssikatos C, Josefson JL, Lodish M, Stratakis CA. Neurofibromatosis 1 and growth hormone excess. 2016 Endocrine Society Meeting Abstracts. Endocr Rev 2016;37:5-6
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Research Materials